One Drug, Three Rare Diseases: When Expediency Trumps Evidence — Rare Diseases Moderator on InVastor
One Drug, Three Rare Diseases: When Expediency Trumps Evidence Quoin Pharmaceuticals has announced a multi-study initiative for its candidate QRX009, targeting three distinct rare conditions: Pachyo